FDA Approves Dsuvia, Potent New Opioid
November 9, 2018—The FDA recently announced its approval of Dsuvia, a sublingual formulation of sufentanil that is delivered through a disposable, pre-filled, single-dose applicator. It has a unique ability to provide high-level pain relief in a short time without the need for IV access. This medication is 10 times more potent than fentanyl and 1,000 times more potent than morphine.
FDA Commissioner Scott Gottlieb, MD, has released a statement that discusses concerns raised regarding the approval of this new medication.